...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay
【24h】

Thiosemicarbazones and 4-thiazolidinones indole-based derivatives: Synthesis, evaluation of antiproliferative activity, cell death mechanisms and topoisomerase inhibition assay

机译:三硫代虫虫草和4-噻唑烷酮吲哚基衍生物:合成,抗增殖活性评价,细胞死亡机制和拓扑异构酶抑制测定

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, we report the synthesis and structural characterization of a series of thiosemicarbazone and 4-thiazolidinones derivatives, as well as their in vitro antiproliferative activity against eight human tumor cell lines. For the most potent compound further studies were performed evaluating cell death induction, cell cycle profile, ctDNA interaction and topoisomerase II alpha inhibition. A synthetic three-step route was established for compounds (2a-e and 3a-d) with yields ranging from 32 to 95%. Regarding anti proliferative activity, compounds 2a-e and 3a-d showed mean GI(50) values ranging between 1.1 mu M (2b) 84.65 mu M (3d). Compound 2b was the most promising especially against colorectal adenocarcinoma (HT-29) and leukemia (K562) cells (GI(50) = 0.01 mu M for both cell lines). Mechanism studies demonstrated that 24 h-treatment with compound 2b (5 mu M) induced phosphatidylserine residues exposition and G2/M arrest on HT-29 cells. Moreover, 2b (50 mu M) was able to interact with ctDNA and inhibited topoisomerase II alpha activity. These results demonstrate the importance of thiosemicarbazone, especially the derivative 2b, as a promising candidate for anticancer therapy. 2017 Elsevier Masson SAS. All rights reserved.
机译:在这项研究中,我们报道了一系列硫代蓟虫酮和4-噻唑烷酮衍生物的合成和结构表征,以及它们对8个人肿瘤细胞系的体外抗增殖活性。对于最有效的化合物,进一步研究进行评估细胞死亡诱导,细胞周期谱,CTDNA相互作用和拓扑异构酶IIα抑制。为化合物(2A-E和3A-D)建立了合成的三步途径,产率范围为32-95%。关于抗增殖活性,化合物2A-E和3A-D显示平均Gi(50)值,范围为1.1μm(2b)84.65μm(3d)。化合物2B是最有前途的,特别是对抗结肠直肠腺癌(HT-29)和白血病(K562)细胞(两种细胞系的GI(50)=0.01μm)。机制研究证明,用化合物2B(5μm)诱导磷脂酰丝氨酸残基阐述的24小时处理和HT-29细胞的G2 / M停滞。此外,2B(50μm)能够与CTDNA相互作用并抑制拓扑异构酶IIα活性。这些结果证明了硫代吡吩,特别是衍生物2B的重要性,作为抗癌治疗的有希望的候选者。 2017年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号